FISH--a new noninvasive method for the diagnosis of urinary bladder carcinomas.
Urinary bladder carcinoma is one of the most frequent malignant tumour diseases. The frequency increases with advancing age. The knowledge increase about genetic changes in tumour cells opens the possibility of a new noninvasive diagnosis with the help of fluorescence in situ hybridization (FISH). Comparable data are obtained by application of different diagnostic methods (fluorescence in situ hybridization, urinary bladder cancer ELISA, urinary cytology, histopathology) at different times from 6 coincidentally selected patients (preoperation, biopsy material and postoperation). The FISH test proved to be a sensitive method and correlated with the histopathological data.
Lübbe
Lieselotte
L
Institute of Pathology, Carl-Thiem Clinic, Cottbus, Germany.
Nowack
Rudolf
R
May
Matthias
M
Ullmann
Kerstin
K
Gunia
Sven
S
Kaufmann
Olaf
O
Hakenberg
Oliver
O
Muche
Joachim
J
Hoschke
Bernd
B
D001706:Biopsy; D002295:Carcinoma, Transitional Cell / Q000175:diagnosis* / Q000473:pathology; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D006801:Humans; D017404:In Situ Hybridization, Fluorescence / Q000379:methods*; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis* / Q000473:pathology; D014556:Urine / Q000166:cytology